Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Evgen Pharma hires interim CFO from Faron, chair to retire this month

Tue, 05th Sep 2023 14:22

(Alliance News) - Evgen Pharma on Tuesday said Non-Executive Chair Barry Clare will retire at its next board meeting, and announced the hiring of interim Chief Financial Officer Toni Hanninen.

The Cheshire, England-based clinical stage drug developer, which is focused on sulforaphane-based medicines, said Clare will formally retire on September 21. He has served as chair since Evgen's foundation in 2007 and oversaw its initial public offering in 2015.

Susan Foden, who is currently senior non-executive director, will take over as chair until a permanent successor is appointed. She served as chair of Neurocentrx Pharma Ltd from June 2021 to February 2023, and was appointed as non-executive deputy chair of QBiotics Group Ltd.

Also on Tuesday, Evgen confirmed the appointment of Toni Hanninen as interim CFO, after his predecessor Richard Moulson retired in late July. Hanninen previously was CFO at Turku, Finland-based clinical stage biopharmaceutical firm Faron Pharmaceuticals Ltd.

Chief Executive Officer Huw Jones said of Haninnen: "His proven experience in the AIM market and beyond will be invaluable to [Evgen] as we enter the next phase of our development."

Evgen Pharma shares were up 0.9% at 2.32 pence in London on Tuesday afternoon.

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Jan 2011 14:42

Business picking up for Evolution

Broker Evolution says that trading conditions improved towards the end of 2010. This is inline with other brokers, such as Panmure Gordon and Arden, which have released trading statements and results in recent weeks. Evolution says that there is a growing pipeline of corporate transactions. That

Read more
5 Jan 2011 08:16

Panmure Gordon boosted by US recovery

Stockbroker and investment bank Panmure Gordon has seen a significant improvement in its operating performance in the second half of the year. "Both our UK and US businesses generated operating profits in this six months, in spite of continued challenging trading conditions," it adds. UK investme

Read more
19 Nov 2010 15:31

Small caps round-up: Huntsworth, Porvair

Shares in public relations outfit Huntsworth fell back after it said some of the revenues it had expected to come in this year will be delayed until 2011. It also announced that finance director Tymon Broadhead is stepping down to be replaced by Colin Adams, currently finance boss at the Harry Pott

Read more
19 Oct 2010 17:49

No Evolution bid for Panmure

Evolution says that it has decided not to bid for fellow broker Panmure Gordon. Evolution says that it reviews Panmure's interim results and subsequently made an indicative conditional proposal to Panmure's board. That proposal was rejected and Evolution does not believe that further discussions a

Read more
15 Oct 2010 15:49

QInvest considering options for Panmure stake

It appears that Evolution may have more chance of acquiring rival broker Panmure Gordon than first thought because QInvest is rumoured to be considering selling its 44% stake in the broker. Ironically, Qatar-based investment bank QInvest has asked Lazard to advise it on its options. Lazard used to

Read more
8 Oct 2010 17:29

Evolution given Panmure bid deadline

The Takeover Panel has told broker Evolution that it has until 5pm on 28 October to make a firm bid for Panmure Gordon. Fully listed Evolution has said that it is interested in buying its AIM-quoted rival but has put no firm proposals on the table. If it does not make a bid by the deadline it will

Read more
23 Sep 2010 17:03

Evolution ponders Panmure bid

Broker and fund manager Evolution Group says that it is considering a bid for AIM-quoted broker Panmure Gordon. Evolution says that a Panmure offer is one of a number of options under consideration. No formal discussions have taken place with Panmure. Evolution says it is waiting to assess Panmu

Read more
25 Mar 2010 08:25

Record breaking year at Evolution

2009 was a record breaking year on many fronts for investment management firm Evolution Group. Group income, private client income, investment banking income and assets under management all hit new highs. Total income more than doubled to £129.4m in 2009 from £63.9m, with investment banking income

Read more
1 Feb 2010 07:39

Evolution doubles FY revenue

Investment management firm Evolution Group said it more than doubled full year revenue after a strong performance across all of its divisions in the second half. Increased activity in the second half of the year and it growing business pipeline makes the group confident full year earnings will be i

Read more
9 Nov 2009 06:18

Monday newspaper round-up: Cadbury, RBS/Lloyds, Vodafone

Kraft, the American food company, is poised to initiate a hostile takeover bid for Cadbury today at or slightly above the offer it made in September, which valued the British confectioner at £10.2bn, according to a person familiar with the deal. Last night Kraft was finalising plans to go directly

Read more
2 Nov 2009 16:30

Broking boss makes £2.6m profit

Evolution chief executive Alex Snow has sold £5.2m of shares after being awarded 4.59m shares from two company option schemes after the vesting conditions for the shares were met. The Evolution Group Plc 2000 Executive Share Option Scheme issued 3.09m shares to Snow, Of these, 2.026m did not have

Read more
30 Oct 2009 06:11

Friday tips round-up: AstraZeneca, Kazakhmys, Standard Life

AstraZeneca posted a sparkling set of third-quarter results on Thursday, sending analysts scurrying away to upgrade their numbers. Pre-tax profits rocketed by 24pc, on revenues up 5pc. On closer inspection, however, the results were flattered by a series of ?one-off gains. The Telegraph recommended

Read more
29 Oct 2009 16:23

London close: Shares end near session high

London's top stocks closed near its session high on news that the US economy grew faster than expected in the third quarter. Traders loved news that the US economy grew 3.5% annually in the last quarter, more than expected and the fastest rate of increase in two years. Part-nationalised bank Lloyd

Read more
29 Oct 2009 14:55

London afternoon: Blue chips track US advance

America's return to growth in the third quarter, stronger UK banks and a better mining sector have propelled London far into the blue Thursday. Traders loved news that the US economy grew 3.5% annually in the last quarter, more than expected and the fastest rate of increase in two years. Part-nati

Read more
29 Oct 2009 12:11

FTSE 250 movers: CSR jumps as chip sales impress

CSR, which makes chips for Bluetooth and Global Positioning System (GPS) devices, is sharply higher after third quarter results were better than expected. Pre-tax profits for the period totalled $10.7m compared with a $30.8m over the same period the previous year. Revenues climbed to $219.9m from $

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.